Latest Administration News

Nova Minerals has sent out its Scheme Booklet to shareholders and warrantholders, setting the stage for a May 29 vote on its proposed move from Australia to the US. The Independent Expert backs the scheme, and directors recommend approval.

Lake Resources made solid progress on the Exploitation Environmental Impact Assessment for its Kachi Lithium Brine Project, targeting approval in Q3 2026, while maintaining strong liquidity and strategic partnerships.

Amplia Therapeutics reported mature ACCENT trial data showing improved survival and multiple complete responses with narmafotinib, alongside a GMP production milestone and CFO appointment.

Nexsen Limited has cleared a major FDA regulatory hurdle for its StrepSure rapid Group B Streptococcus test, confirmed a clear 510(k) submission pathway, and secured over A$1.7 million in non-dilutive grants to expand clinical validation and market rollout in Asia-Pacific and neonatal diagnostics.

PYC Therapeutics fortified its balance sheet by $600 million and progressed key RNA therapeutic trials in Q1 2026, setting the stage for pivotal clinical data and regulatory submissions.

Cambium Bio has clinched FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development complexity, while bolstering its cash position through a A$2.4 million strategic placement by major shareholder ZYBT.

LTR Pharma has wrapped up recruitment for its SPONTAN Phase II pharmacokinetic study, with interim results expected soon to bolster FDA approval efforts. Meanwhile, US commercial talks for ROXUS advance cautiously under the FDA 503(a) personalised medicine pathway.

Algorae Pharmaceuticals has struck an exclusive commercial and licensing agreement with global pharma Zydus Lifesciences to bring 10 injectable, oral, and specialty medicines to Australia and New Zealand, pending regulatory approvals.

Firebird Metals has locked in exclusive global rights to key LMFP patents through 2045 and commissioned lithium-manganese-rich cathode equipment, progressing its Australian Demonstration Plant with a $2 million ARENA grant.

Nelson Resources has expanded its footprint at the Gold Point Project with new high-grade gold-silver veins and prepared for maiden drilling, while unlocking significant development potential at Yarri through mining lease grants and a $10 million funding deal.

Carnarvon Energy is gearing up for a high-impact Bedout Sub-basin drilling campaign in the first half of 2027, supported by a robust balance sheet and strategic investments.

Black Canyon Limited has delivered robust metallurgical results confirming high-quality direct shipping ore (DSO) potential for manganese and iron at its Wandanya Project, alongside commencing a major 15,000m drilling campaign to define and expand resources.